Fig 1: Interleukin (IL)-23, IL-17, IL-22, IL-12, and interferon (IFN)-? expression in each of the four groups. In the psoriasiform chronic dermatitis group, there was significantly increased expression of IL-12 observed in the lesional dermis (2.40±1.07) compared with the group showing non-psoriasiform dermatitis with moderate to severe epidermal hyperplasia (1.40±0.52) and the group with non-psoriasiform dermatitis with mild epidermal hyperplasia (1.60±0.52) (p<0.05). However, the IL-23, IL-17, IL-22, and IFN-? expression in the epidermis of the psoriasiform chronic dermatitis group showed no statistically significant differences compared with the other 2 atopic dermatitis (AD) groups (×200, scale bar: 500 µm).
Supplier Page from Abcam for Anti-IL-23 antibody - N-terminal